Valuation: Formycon AG

Market Cap 329M 380M 306M 282M 532M 36.09B 538M 3.6B 1.41B 18.06B 1.43B 1.39B 59.8B P/E 2026 *
-30.6x
P/E 2027 * 10.6x
Enterprise Value 398M 459M 371M 341M 644M 43.67B 651M 4.36B 1.71B 21.85B 1.72B 1.69B 72.36B EV / Sales 2026 *
5.47x
EV / Sales 2027 * 3.66x
Free-Float
70%
Yield 2026 *
-
Yield 2027 * -
1 day+0.91%
1 week-3.12%
Current month-2.71%
1 month-3.42%
3 months+0.54%
6 months-18.87%
Current year-27.11%
1 week 18.6
Extreme 18.6
19.54
1 month 17.68
Extreme 17.68
19.58
Current year 15.8
Extreme 15.8
26.95
1 year 15.8
Extreme 15.8
26.95
3 years 15.8
Extreme 15.8
69.6
5 years 15.8
Extreme 15.8
94.1
10 years 14.65
Extreme 14.65
94.1
Manager TitleAgeSince
Chief Executive Officer - 01/07/2022
Director of Finance/CFO 57 01/04/2023
Chief Tech/Sci/R&D Officer - 01/07/2022
Director TitleAgeSince
Director/Board Member 49 10/12/2020
Chairman 54 12/06/2024
Director/Board Member 54 12/06/2024
Date Insider Type Main position Quantity % Market Cap.
21/02/25 Buy

Chief Technology Officer

160 0.0009%
29/04/24 Buy

Executive/Senior Manager

1,200 0.0068%
24/04/24 Buy

Chief Executive Officer

2,500 0.0142%
Change 5-day change 1-year change 3-year change Capi.($)
+0.91%-3.12%-27.25%-72.27% 380M
+1.12%-0.42%+4.11%+15.83% 48.57B
+1.98%+9.05%+413.94%+532.17% 41.95B
+3.44%-4.65%+28.34%+8.81% 38.85B
+1.40%+0.10%+6.61%+61.93% 37.24B
+2.42%+5.72%+12.38%+44.79% 30.67B
-0.16%-3.11% - - 16.1B
+2.20%+0.48%+34.71%+127.15% 16.41B
+0.40%+1.98%+8.30%+19.14% 13.97B
+4.25%-8.23%-1.49%-35.46% 12.62B
Average +1.80%-0.88%+53.29%+78.01% 25.67B
Weighted average by Cap. +1.91%-0.12%+82.88%+120.48%

Financials

2026 *2027 *
Net sales 72.73M 83.98M 67.8M 62.36M 118M 7.99B 119M 797M 313M 4B 315M 308M 13.23B 121M 140M 113M 104M 196M 13.32B 199M 1.33B 522M 6.67B 526M 515M 22.08B
Net income -10.92M -12.61M -10.18M -9.36M -17.68M -1.2B -17.87M -120M -46.96M -600M -47.36M -46.32M -1.99B 30.87M 35.64M 28.78M 26.47M 49.96M 3.39B 50.52M 338M 133M 1.7B 134M 131M 5.62B
Net Debt 69.04M 79.71M 64.36M 59.19M 112M 7.58B 113M 756M 297M 3.79B 299M 293M 12.56B 115M 133M 107M 98.51M 186M 12.61B 188M 1.26B 494M 6.31B 498M 487M 20.9B
Logo Formycon AG
Formycon AG is a Germany based Company. The Company is engaged in providing biosimilar drugs and formulations. The Company focuses on treatments in ophthalmology, immunology and other chronic diseases, covering all steps of biosimilar development process, from early-stage analysis of the originator drug to the preclinical and clinical testing phases, as well as the preparation of dossiers for marketing approval.
Employees
203
Date Price Change Volume
06/08/26 18.66 +0.32% 1
05/08/26 €18.60 -2.31% 2,889
04/08/26 €19.04 +0.21% 5,004
03/08/26 €19.00 -0.94% 3,572
31/07/26 €19.18 -0.42% 368
Trader
Investor
-
Global
-
Quality
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
18.60EUR
Average target price
39.67EUR
Spread / Average Target
+113.26%

Quarterly revenue - Rate of surprise